6.1 Cognitive Impairment Risk Recognition

ANCC GERO-BC Domain I (Assessment and Diagnosis), knowledge area I-B-2 (risk factor identification), expects you to recognize who is at elevated risk for cognitive decline—and to act before crises force recognition. Cognitive impairment risk identification is not the same as diagnosing dementia. Your job is to detect vulnerability early, separate acute reversible syndromes from progressive neurodegenerative patterns, and escalate screening, safety measures, and interdisciplinary evaluation when risk clusters appear.

Why Risk Recognition Matters

Undetected cognitive decline drives falls, medication nonadherence, financial exploitation, missed diagnoses, hospital readmissions, and caregiver burnout. Many older adults compensate for years with calendars, spouses who “fill in” answers, and simplified routines. Risk recognition helps you look behind that compensation.

Treat cognitive risk as multifactorial. A single risk factor rarely predicts impairment by itself; clusters of vascular, sensory, psychosocial, and pharmacologic risks raise concern sharply.

Nonmodifiable and Modifiable Risk Factors

High-yield modifiable targets for nursing assessment

1. Hearing and vision — ask about TV volume, missed conversation, unread mail; refer for audiology/optometry when deficits appear.
2. Vascular control — trend BP, A1C, anticoagulation adherence after AF/stroke.
3. Deprescribing risk — flag Beers-criteria CNS-active drugs that cloud attention and memory.
4. Sleep apnea clues — loud snoring, daytime somnolence, resistant hypertension, witnessed apneas.
5. Isolation — living alone after bereavement, no phone contact, missed meals delivered by others.

Exam cue: Items often pair a “forgetful” older adult with a reversible driver (new benzodiazepine, untreated hearing loss, UTI with fluctuating attention). Identify the risk cluster before labeling permanent dementia.

Delirium Risk vs Dementia Risk vs Depression

GERO-BC repeatedly tests whether you can tell syndrome patterns apart while still recognizing overlapping risk.

Delirium-specific risk factors to identify early

• Age ≥65, preexisting cognitive impairment, sensory impairment
• Polypharmacy / new psychoactive medication
• Infection, dehydration, electrolyte imbalance, hypoxia, uncontrolled pain
• Immobilization, restraints, disrupted sleep–wake cycle
• Surgery (especially orthopedic/cardiac), ICU stay, Foley catheter

Use tools such as CAM/CAM-ICU when acute change plus inattention appear. Delirium risk identification is preventive: minimize tethers, restore glasses/hearing aids, optimize sleep, review meds, and mobilize.

Dementia-spectrum risk recognition

For progressive impairment risk, watch for instrumental ADL erosion (finances, meds, driving, cooking) before basic ADLs fail. Vascular risk clustering suggests mixed or vascular cognitive impairment. Rapid week-to-week decline is atypical for typical Alzheimer disease and should push workup for delirium, infection, subdural hematoma, medication toxicity, or other acute processes.

Depression as both risk and mimic

Late-life depression increases later dementia risk and can present with concentration and memory complaints (“pseudodementia” is an outdated oversimplification—screen for both). Positive GDS/PHQ plus cognitive complaints means treat mood and reassess cognition after mood improves; do not assume permanent dementia from a single depressed assessment.

Early Clinical Red Flags

Risk identification often starts with collateral history and functional clues rather than a formal score.

Functional and behavioral red flags

• Repeating questions within the same visit; losing the thread of conversation
• Missed appointments, wrong-day arrivals, or inability to recount recent events
• New medication errors, duplicate fills, or unexplained subtherapeutic levels
• Unpaid bills, unusual purchases, or susceptibility to phone scams
• Getting lost on familiar routes; GPS dependence that is new
• Decline in cooking, shopping, or medication management (IADL failure)
• Word-finding pauses that worsen; difficulty following multistep instructions
• Personality change, apathy, or new disinhibition (frontotemporal clues)
• Caregiver saying “they’re just not themselves” with concrete examples

When to escalate beyond watchful waiting

Escalate structured cognitive screening and medical evaluation when:

1. The person or caregiver reports progressive decline affecting function.
2. Safety risks appear (driving near-misses, stove left on, wandering).
3. Acute fluctuation suggests delirium until proven otherwise.
4. New psychoactive medications or metabolic abnormalities coincide with decline.
5. Decision-making capacity for treatment or discharge is uncertain.

Document baseline cognition whenever possible—admission MoCA/MMSE/SLUMS or a clear description of orientation, attention, and IADL status—so later change is measurable.

Reversible and Partially Reversible Contributors

Always ask: What could be reversible here? Classic “treatable” contributors include:

Nursing Role: From Risk to Action

Risk recognition without action is incomplete assessment.

1. Screen appropriately — MoCA/MMSE/SLUMS for suspected chronic decline; CAM for acute change; depression tools by cognition level.
2. Protect safety — falls, wandering, medication mismanagement, financial vulnerability, driving concerns.
3. Engage caregivers — obtain collateral; teach warning signs; assess caregiver stress.
4. Address modifiable risks — hearing aids, vascular control, sleep, socialization, deprescribing.
5. Coordinate — primary care, geriatrics, neurology, pharmacy, social work, audiology as indicated.
6. Avoid premature labeling — document observations and scores; reserve diagnostic language for the evaluating clinician/team.

Exam Focus

GERO-BC items on cognitive impairment risk typically ask which factor most increases risk, which finding suggests delirium rather than dementia, or what the nurse should do next after identifying red flags. Prioritize reversible contributors, safety, and the correct screening pathway over jumping to a permanent dementia label.